ReEmerge, Inc. Exits Stealth with Oversubscribed $37M Series A to Challenge the Limitations of Chronic Cognitive Impairment Caused by Brain Injuries

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ReEmerge-Launch

More Like This

PR Newswire associated0

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

GlobeNewswire associated0

Breakthrough Shown to Cut Dementia Risk, Now Found to Help Repair Brain Injuries

Precision Medicine Trial Using a Personalised Approach Reports Preliminary Findings on Cognitive Function in Patients with Mild Cognitive Impairment and Early Dementia

ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System

ExQor Technologies Announces Advancement Toward Clinical Trials for Brain Regenerative Medicine Platform to Treat Alzheimer's Disease

2024 rendering of Motif Neurotech's Digitally Programmable Over-brain Therapeutic (DOT). (Photo: Business Wire)

Motif Neurotech Wins UK Government Award to Develop Therapeutic Brain-Computer Interface

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

Mainstay Medical Announces Two-Year Outcomes from RESTORE Clinical Trial of ReActiv8®